期刊文献+

肺炎支原体感染婴幼儿血清免疫球蛋白、补体及促炎/抗炎细胞因子水平的动态变化 被引量:50

The changes of serum immunoglobulin,complement and pre-and anti-inflammatory cytokines in infants with mycoplasma pneumonia
暂未订购
导出
摘要 目的探讨婴幼儿肺炎支原体肺炎(MPP)急性期与恢复期免疫功能的变化。方法入选MPP患儿60例,正常对照儿童60例,采用免疫散射比浊法测定免疫球蛋白(IgM、IgG、IgA)及补体C3、C4水平;ELISA法测定血清TNF-α、IL-8、IL-10、IL-13水平。结果 MPP患儿急性期IgM,补体C3、C4,TNF-α,IL-8,IL-13水平均高于恢复期或正常对照儿童,差异有统计学意义(P均<0.05);MPP患儿急性期IgG水平与正常对照儿童比较,差异无统计学意义(P>0.05),IgA和IL-10水平均低于恢复期和正常对照儿童,差异有统计学意义(P均<0.05)。结论检测MPP患儿免疫球蛋白、补体及促炎/抗炎细胞因子水平的动态变化对判定病情和预后有一定的临床意义。 Objective To investigate the changes in serum concentration of immunoglobulin, complement and cytokines concentrations during acute and recovery phase ofmycoplasma pneumonia (MPP) in infants. Methods Sixty infants with MPP and 60 healthy control infants were enrolled. The levels of serum immunoglobulins (IgM, IgG, IgA) and complements (C3, C4) were detected using immune scatter turbidimetry, and the levels of TNF-α, IL-8, IL-10, and IL-13 were determined by ELISA. Results Compared with infants in the recovery phase and healthy control infants, the levels of IgM, C3, C4, TNF-α, IL-8 and IL-13 were significantly higher in the acute phase (P〈0.05), and the levels of IgA and IL-10 were significantly lower (P〈0.05), while there was no statistical difference in the levels of IgG between the infants in the acute phase and healthy infants (1~〉0.05). Conclusions The detection of the changes of immunoglobulins, complements, pro- and anti-inflammatory cytokines is valuable to assessing the severity of disease and the prognosis of MPP in infants.
机构地区 贵州航天医院
出处 《临床儿科杂志》 CAS CSCD 北大核心 2013年第1期26-29,共4页 Journal of Clinical Pediatrics
关键词 肺炎支原体 免疫球蛋白 细胞因子 婴幼儿 mycoplasma pneumonia immunoglobulin cytokines infant
  • 相关文献

参考文献11

二级参考文献57

  • 1辛德莉,侯安存,魏田力,李靖,马红秋.肺炎支原体对大环内酯类抗生素耐药的分析[J].中华儿科杂志,2005,43(3):212-212. 被引量:85
  • 2陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:625
  • 3丁圣刚,王亚亭.258例儿童支原体肺炎临床及并发症分析[J].临床肺科杂志,2007,12(7):741-742. 被引量:31
  • 4Yang E, Altes T, Anupindi SA. Early Mycoplasma pneumoniae infection presenting as multiple pulmonary masses: an unusual presentation in a child [J]. Pediatr Radiol,2008,38 (4):477- 480.
  • 5Gaillat J, Elahauh A, deBarbeyrae B, et al. Community epidemiology of Chlamydia and Myeoplasma pneumoniae in LRTI in France over 29 months [J]. Eur J Epidemiol,2005,20 (7) :643-651.
  • 6Nagalingam NA, Adesiyun AA, Swanston WH, et al. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad [J]. New Microbiol, 2004,27 (4) : 345 -351.
  • 7Tamura A, Matsubara K, Tanaka T, et all. Methylprednisolone pulse therapy for refractory Mycoplasrna pneumoniae pneumonia in children [J]. J Infect,2008,57(3):223-228.
  • 8Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia [J]. Antimierob Agents Chemother, 2008,52 ( 1 ) : 348-350.
  • 9Pereyre S, Charron A, Renaudin H, et al. First report of macrolideresistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years [J]. J Clin Microbiol ,2007,45 ( 11 ) : 3534-3539.
  • 10Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae [J]. Curr Drug Targets Infect Disord, 2005,5(3) :263-271.

共引文献259

同被引文献420

引证文献50

二级引证文献744

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部